OPNT
Opiant Pharmaceuticals, Inc. Common Stock
OPNT
OPNT
Delisted
OPNT was delisted on the 1st of March, 2023.
37 hedge funds and large institutions have $41.2M invested in Opiant Pharmaceuticals, Inc. Common Stock in 2022 Q4 according to their latest regulatory filings, with 17 funds opening new positions, 7 increasing their positions, 11 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
36% less repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 11
Holders
37
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$8.6M | |
| 2 | +$3.86M | |
| 3 | +$1.26M | |
| 4 |
CL
CSS LLC
Chicago,
Illinois
|
+$1.24M |
| 5 |
RA
Ramius Advisors
New York
|
+$1.12M |
Top Sellers
| 1 | -$2.26M | |
| 2 | -$1.64M | |
| 3 | -$1.39M | |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
-$1.36M |
| 5 |
Renaissance Technologies
New York
|
-$618K |